Suppression of type 1 insulin-like growth factor receptor expression by small interfering RNA inhibits A549 human lung cancer cell invasion in vitro and metastasis in xenograft nude mice

Acta Biochimica et Biophysica Sinica

Volumn 39, Issue 2, 2007, Pages 137-147

  Qian, Jianfang ^a   Dong, Aiqiang ^a   Kong, Minjian ^a   Ma, Zhiyuan ^b   Fan, Junqiang ^a   Jiang, Guanyu ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Invasion; Lung cancer; Metastasis; Small interfering RNA; Type 1 insulin like growth factor receptor

Indexed keywords

SMALL INTERFERING RNA; SOMATOMEDIN C RECEPTOR;

ANIMAL; ARTICLE; CANCER INVASION; GENETICS; HUMAN; LUNG TUMOR; MOUSE; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; RECEPTOR, IGF TYPE 1; RNA, SMALL INTERFERING; TRANSPLANTATION, HETEROLOGOUS;

MUS MUSCULUS;

EID: 33846988211     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1111/j.1745-7270.2007.00257.x     Document Type: Article

References (40)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin 2000, 50: 7-33
2. Steeg PS. Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer 2003, 3: 55-63
3. Macaulay VM, Salisbury AJ, Bohula EA, Playford MP, Smorodinsky NI, Shiloh Y. Downregulation of the type 1 insulin-like growth factor in mouse melanoma cells is associated with enhanced radiosensitivity and impaired activation of Atm kinase. Oncogene 2001, 20: 4029-4040
4. Benini S, Manara MC, Baldini N, Cerisano V, Massimo Serra, Mercuri M, Lollini PL et al. Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cells. Clin Cancer Res 2001, 7: 1790-1797
5. Moore FD Jr, Lee SJ. Staging and prognostic factors: Non-small cell lung cancer. In: Pass IH, Mitchell BJ, Johnson HD, Turrisi TA, eds. Lung Cancer: Principles and Practice, 1st edn. Philadelphia: Lippincott-Raven Publishers 1996
6. Frei E 3rd. Non-small cell lung cancer: Novel treatment strategies. Chest 1997, 112: 266S-268S
7. Fukunaga M, Takamori S, Hayashi A, Shirouzu K, Kosai K. Adenoviral herpes simplex virus thymidine kinase gene therapy in an orthotopic lung cancer model. Ann Thorac Surg 2002, 73: 1740-1746
8. Kwong YL, Chen SH, Kosai K, Finegold M, Woo SL. Combination therapy with suicide and cytokine genes for hepatic metastases of lung cancer. Chest 1997, 112: 1332-1337
9. Zhang D, Samani AA, Brodt P. The role of the IGF-I receptor in the regulation of matrix metalloproteinases, tumor invasion and metastasis. Horm Metab Res 2003, 35: 802-808
10. Brodt P, Samani A, Navab R. Inhibition of the type I insulin-like growth factor receptor expression and signaling: Novel strategies for antimetastatic therapy. Biochem Pharmacol 2000, 60: 1101-1107
11. Rotsch M, Maasberg M, Erbil C, Jaques G, Worsch U, Havemann K. Characterization of insulin-like growth factor I receptors and growth effects in human lung cancer cell lines. J Cancer Res Clin Oncol 1992, 118: 502-508
12. Lee CT, Park KH, Adachi Y, Seol JY, Yoo CG, Kim YW, Han SK et al. Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effects on lung cancer. Cancer Gene Ther 2003, 10: 57-63
13. Jiang Y, Rom WN, Yie TA, Chi CX, Tchou-Wong KM. Induction of tumor suppression and glandular differentiation of A549 lung carcinoma cells by dominant-negative IGF-I receptor. Oncogene 1999, 18: 6071-6077
14. van Golen CM, Schwab TS, Kim B, Soules ME, Su Oh S, Fung K, van Golen KL et al. Insulin-like growth factor-I receptor expression regulates neuroblastoma metastasis to bone. Cancer Res 2006, 66: 6570-6578
15. Burfeind P, Chernicky CL, Rininsland F, Ilan J, Ilan J. Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in xenograft nude mice. Proc Natl Acad Sci USA 1996, 93: 7263-7268
16. Bauer TW, Fan F, Liu W, Johnson M, Parikh NU, Parry GC, Callahan J et al. Insulin like growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor. Ann Surg 2005, 241: 748-756
17. Zhang D, Brodt P. Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling. Oncogene 2003, 22: 974-982
18. Brodt P, Fallavollita L, Khatib AM, Samani AA, Zhang D. Cooperative regulation of the invasive and metastatic phenotypes by different domains of the type I insulin-like growth factor receptor beta subunit. J Biol Chem 2001, 276: 33608-33615
19. Guvakova MA, Adams JC, Boettiger D. Functional role of α-actinin, PI3-kinase and MEK1/2 in insulin-like growth factor I receptor kinase regulated motility of human breast carcinoma cells. J Cell Sci 2002, 115: 4149-4165
20. Sachdev D, Hartell JS, Lee AV, Zhang X, Yee D. A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells. J Biol Chem 2004, 279: 5017-5024
21. Dunn SE, Ehrlich M, Sharp NJ, Reiss K, Solomon G, Hawkins R, Baserga R et al. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. Cancer Res 1998, 58: 3353-3361
22. Uprichard SL. The therapeutic potential of RNA interference. FEBS Lett 2005, 579: 5996-6007
23. Miyagishi M, Taira K. U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat Biotechnol 2002, 20: 497-500
24. Zhang H, Ma G, Dong M, Zhao M, Shen X, Ma Z, Guo K. Epidermal growth factor promotes invasiveness of pancreatic cancer cells through NF-κB-mediated proteinase productions. Pancreas 2006, 32: 101-109
25. Rochester MA, Riedemann J, Hellawell GO, Brewster SF, Macaulay VM. Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer. Cancer Gene Ther 2005, 12: 90-100
26. Peng PL, Hsieh YS, Wang CJ, Hsu JL, Chou FP. Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Toxicol Appl Pharmacol 2006, 214: 8-15
27. Liang Z, Yoon Y, Votaw J, Goodman MM, Williams L, Shim H. Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res 2005, 65: 967-971
28. MacKay AR, Corbitt RH, Hartzler JL, Thorgeirsson UP. Basement membrane type IV collagen degradation: Evidence for the involvement of a proteolytic cascade independent of metalloproteinases. Cancer Res 1990, 50: 5997-6001
29. Sekharam M, Zhao H, Sun M, Fang Q, Zhang Q, Yuan Z, Dan HC et al. Insulin-like growth factor 1 receptor enhances invasion and induces resistance to apoptosis of colon cancer cells through the Akt/Bcl-x(L) pathway. Cancer Res 2003, 63: 7708-7716
30. Dunn SE, Torres JV, Oh JS, Cykert DM, Barrett JC. Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase. Cancer Res 2001, 61: 1367-1374
31. Yoeli-Lerner M, Toker A. Akt/PKB signaling in cancer: A function in cell motility and invasion. Cell Cycle 2006, 5: 603-605
32. Samani AA, Yakar S, Leroith D, Brodt P. The role of the IGF system in cancer growth and metastasis: Overview and recent insights. Endocr Rev 2006, Aug 24 [Epub ahead of print]
33. Holen T, Amarzguioui M, Wiiger MT, Babaie E, Prydz H. Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res 2002, 30: 1757-1766
34. Harborth J, Elbashir SM, Vandenburgh K, Manninga H, Scaringe SA, Weber K, Tuschl T. Sequence, chemical and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense Nucleic Acid Drug Dev 2003, 13: 83-105
35. Zelenka PS. Regulation of cell adhesion and migration in lens development. Int J Dev Biol 2004, 48: 857-865
36. Tai YT, Podar K, Catley L, Tseng YH, Akiyama M, Shringarpure R, Burger R et al. Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of beta1-integrin and phosphatidylinositol 3′-kinase/AKT signaling. Cancer Res 2003, 63: 5850-5858
37. Leventhal PS, Feldman EL. Insulin-like growth factors as regulators of cell motility-signaling mechanisms. Trends Endocrinol Metab 1997, 8: 1-6
38. Felding-Habermann B. Integrin adhesion receptors in tumor metastasis. Clin Exp Metastasis 2003, 20: 203-213
39. Andreasen PA, Kjoller L, Christensen L, Duffy MJ. The urokinase-type plasminogen activator system in cancer metastasis: A review. Int J Cancer 1997, 72: 1-22
40. Westermarck J, Kahari VM. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 1999, 13: 781-792